Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of MK0493 in Obese Patients
NCT00482638Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- May 2004
- Primary completion
- Oct 2004
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in obesity comparing MK0493 with Placebo (2 arms). Started May 2004; status: completed.
02
Drugs
MK-0493
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00482638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00482638.